Veradermics, Incorporated

MANE · Pharmaceutical Preparations · $4.5B
MANE
$106.75
▼ −1.78%
09/18 O 109.30 H 109.30 L 104.54 C 106.75 ▼ −1.78%
Vol 1.9M RS not ranked yet
RS ratingnot ranked yet
Now vs pivot (%)−18.66%
Tightening (ATR ratio)1.53×
Volume dry-up1.12×
Up/down volume, net0.02
From 52-week high19%
forming
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter

No 200-day line: this stock has under a year of daily history.

The read

The base has run 11.2 weeks and fell 29% from its ceiling at its deepest. The pivot is $131.24, and the stock closed 18.7% below it. Its relative strength rating is not ranked yet.

Peers
Catalyst roadmap
  1. EarningstentativeLLY · competitorin 41d
    LLY reports
    Oct 29, 2026
  2. Earningstentativein 55d
    Quarterly earnings
    Nov 12, 2026
Flagged by the market sweep
Several insiders soldInsider · 2026-09-18
1 insiders sold $80,437,500
GappedTape · 2026-09-18
+6.1%
Several insiders soldInsider · 2026-09-17
1 insiders sold $80,437,500
Several insiders soldInsider · 2026-09-16
1 insiders sold $80,437,500
Several insiders soldInsider · 2026-09-15
1 insiders sold $80,437,500
Several insiders soldInsider · 2026-09-12
1 insiders sold $80,437,500
Several insiders soldInsider · 2026-09-11
1 insiders sold $80,437,500

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.

In the news

No headlines for this company in the last couple of weeks.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Veradermics, Incorporated (MANE) — The Tape